Published online Sep 6, 2025. doi: 10.12998/wjcc.v13.i25.97335
Revised: October 30, 2024
Accepted: May 21, 2025
Published online: September 6, 2025
Processing time: 404 Days and 22.1 Hours
Aging is an inevitable aspect of human life, characterized by the gradual decline in the function of individual cells and structural components, including bones, muscles, and ligaments.
To evaluate the clinical effects of radiofrequency technology in treating facial skin wrinkles and laxity.
This study included 60 female patients, aged 36-58 years (mean age 47.71 ± 1.56 years), who received focused radiofrequency technology treatment for facial wrinkles and laxity in the Department of Medical Cosmetology at our hospital between January 2021 and June 2022. Each patient underwent three treatment sessions, one every two months. Facial photographs were taken before treatment and one week after the final session. A single physician assessed wrinkle severity using a standardized wrinkle severity scale, and patients completed a satisfaction questionnaire one week after the last treatment.
After three consecutive radiofrequency treatments, performed every two months, patients exhibited significantly reduced wrinkles and skin laxity compared to baseline. One week after the third treatment, the mean facial wrinkle severity score had significantly decreased from 3.00 ± 0.79 to 2.71 ± 0.47 (t = 2.58, P < 0.05). Additionally, 88.24% of patients reported noticeable improvements in facial wrinkles and skin laxity. No serious adverse reactions occurred during or follow
Radiofrequency technology demonstrates significant clinical efficacy in improving facial skin wrinkles and laxity.
Core Tip: Radiofrequency technology has a remarkable clinical effect on the improvement of facial skin wrinkles and relaxation. To assess clinical efficacy of radiofrequency for facial wrinkles/laxity, 60 female patients received three focused radiofrequency treatments for facial aging at a medical cosmetology department. Post-treatment, the mean facial wrinkle severity score decreased significantly. 88.24% of patients reported noticeable improvements. No serious adverse events occurred.